FRM
RMTI icon

Fox Run Management’s Rockwell Medical RMTI Stock Holding History

Fox Run Management’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-284
Closed -$236K – 655
2016
Q2 		$236K Buy
+284
New +$264K 0.11% 378

Other funds holding RMTI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BA
BKS Advisors Southfield, Michigan $249M AUM 14.37% 1-Year Est. Return

Fox Run Management's RMTI Position: Q3 2016 in Review

Fox Run Management sold out of Rockwell Medical (RMTI) in Q3 2016, closing a stake of 284 shares — an estimated $236K sold.

Fox Run Management first reported a position in RMTI in Q2 2016 and held it in 1 quarter. The position peaked at $236K in Q2 2016. 88 funds tracked by Wall St. Rank hold RMTI as of Q3 2016.

  • Fox Run Management reported no remaining Rockwell Medical position as of Q3 2016 after selling out during the quarter.
  • Fox Run Management sold 284 Rockwell Medical shares in Q3 2016, an estimated $236K.
  • Fox Run Management first reported a position in Rockwell Medical in Q2 2016 and held it in 1 quarter.
  • Fox Run Management's Rockwell Medical position peaked at $236K in Q2 2016.
  • 88 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2016.

Based on Fox Run Management's 13F filing for Q3 2016, filed 12 Oct 2016.